Position in CDXS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,910,670
+$918,656 QoQ
Shares Held
845,431
+38.9% QoQ
Ownership
0.772%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 148 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. CDXS ranks #126 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in CDXS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,910,670 | 845,431 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $992,014 | 608,601 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $105,419 | 64,675 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $205,127 | 84,069 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $206,316 | 84,556 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $209,905 | 78,032 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $494,318 | 103,631 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $968,535 | 314,460 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $735,541 | 237,272 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $453,933 | 130,067 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $576,354 | 188,969 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,349,210 | 713,868 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,145,528 | 766,260 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,017,277 | 487,265 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,029,957 | 221,021 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $886,565 | 146,298 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $231,845 | 22,165 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,404,490 | 68,113 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $727,777 | 23,274 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $184,024 | 15,675 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||